Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT05022563
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea
100,000
Enrollment(s)
2
Study location(s)
Observational
Venous Thromboembolism
Withdrawn
NCT04676243
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
0
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Acute Myeloid Leukemia
Completed
NCT04425902
Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults
20
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
HIV Infections
Terminated
NCT03552029
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
10
Enrollment(s)
8
Study location(s)
Interventional (Phase I)
Acute Myeloid Leukemia
Recruiting
NCT04542408
Hamburg Edoxaban for Anticoagulation in COVID-19 Study
172
Enrollment(s)
10
Study location(s)
Interventional (Phase III)
Covid19
Completed
NCT02371369
Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
120
Enrollment(s)
39
Study location(s)
Interventional (Phase III)
Pigmented Villonodular Synovitis
Giant Cell Tumors of the Tendon Sheath
Tenosynovial Giant Cell Tumor
Active, not recruiting
NCT02744092
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
811
Enrollment(s)
151
Study location(s)
Interventional (Not Applicable)
Cancer
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Blood Clot
Completed
NCT03247569
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)
300
Enrollment(s)
6
Study location(s)
Observational
Atrial Fibrillation
46
47
48
49
50